In the shadow of President Trump's efforts to lower drug prices, the Medicare drug price negotiation process that began in ...

More than 700,000 Medicare beneficiaries currently face permanent increases in their Part B premiums because of late enrollment, with average penalties reaching 30 percent.

Medicare Part B drug negotiations in 2028 pose challenges for providers, requiring new payment systems and strategies to ...

Medicare Advantage may lure seniors with slick perks and shiny star ratings, but many soon find themselves tangled in red ...

While many MA beneficiaries appreciate the flexibility of choosing their own support, others face barriers like limited card ...

Drug pricing and reimbursement constraints are a major concern for the pharmaceutical industry. In order to balance ...

There is a nearly five-year gap between when a new medical device receives FDA approval and is subsequently covered by ...

Rigorous answers about the program’s effects on drug innovation are still a ways off. However, some information about ...

More than half of older Americans now get their Medicare coverage through an insurance company's Medicare Advantage plan.

The Health Resources and Services Administration has overseen the 340B Drug Pricing Program since its creation in 1992. That ...

Some common retirement choices can increase your tax burden. Learn how to avoid costly mistakes and keep more of the savings ...

It is not income-based. Anyone who receives Medicare Part A and/or Part B is also eligible for Part D. The decision to enroll and which plan to choose should be made in consideration with one’s ...